Bellicum Pharmaceuticals, Inc.

BLCMNASDAQHealthcare

$0.07

$-0.01(-6.68%)

Market Cap$778326

P/E Ratio—

52W High$1.31

52W Low$0.06

Avg Volume28K

Open$0.08

Beta1.38

Employees Ownership Insider Trades

Bellicum Pharmaceuticals, Inc. (BLCM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BLCM · as of Mar 31, 2023

Latest filing snapshot

+6+85.71%vs prior year

Bellicum Pharmaceuticals, Inc. (BLCM) employee data is sourced from the annual SEC 10-K filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2022-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+85.71%

Revenue / Employee

$115.4K

Net Income / Employee

$-1.92M

Market Cap

$1M

BLCM Employee Count

2014 – 2022 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2023-03-31	2022-12-31	13	+6	+85.71%
2022-03-24	2021-12-31	7	-9	-56.25%
2021-03-31	2020-12-31	16	-91	-85.05%
2020-03-12	2019-12-31	107	-66	-38.15%
2019-03-12	2018-12-31	173	+36	+26.28%
2018-03-13	2017-12-31	137	+22	+19.13%
2017-03-13	2016-12-31	115	+43	+59.72%
2016-03-14	2015-12-31	72	+37	+105.71%
2015-03-20	2014-12-31	35	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

IMPL

Impel Pharmaceuticals Inc.

Acorda Therapeutics, Inc.

102$1M #4

INFIQ

Infinity Pharmaceuticals, Inc.

30$0M #5

BLCM

Bellicum Pharmaceuticals, Inc.YOU

13$1M #6

NMTRQ

9 Meters Biopharma, Inc.

10$0M #7

NVIV

InVivo Therapeutics Holdings Corporation

6$1M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BLCM peer comparison

About BLCM employees

BLCM Employees · Headcount

Bellicum Pharmaceuticals, Inc. (BLCM) employee data is sourced from the annual SEC 10-K filing. As of 2022, Bellicum Pharmaceuticals, Inc. had 13 full-time employees globally. Full-time employees only. Global consolidated headcount.

Bellicum Pharmaceuticals, Inc. employs 13 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $115,385, reflecting the company's operational efficiency.

Bellicum Pharmaceuticals, Inc.'s workforce increased by 6 (85.71%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Bellicum Pharmaceuticals, Inc.'s revenue per employee of $115,385 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

BLCM Employees · 5 questions

As of the latest SEC 10-K filing (2022), Bellicum Pharmaceuticals, Inc. had 13 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Bellicum Pharmaceuticals, Inc. employee counthow many employees does Bellicum Pharmaceuticals, Inc. haveBLCM total employees 2022

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2023-03-31